Market Research Logo

Global Esophageal Cancer Market and Competitive Landscape – 2017

Global Esophageal Cancer Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Esophageal Cancer Market and Competitive Landscape – 2017, provides comprehensive insights into Esophageal Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Esophageal Cancer market size and drug sales. This research also provides insights into Esophageal Cancer epidemiology and late stage pipeline.
The report is classified into twelve sections – Esophageal Cancer overview with definitions, symptoms, etiology, diagnosis, treatment options; Esophageal Cancer pipeline insights covering late stage clinical trials pipeline; Esophageal Cancer prevalence trends by countries; Esophageal Cancer market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

  • Esophageal Cancer pipeline: Find out the drugs in clinical trials for Esophageal Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Esophageal Cancer epidemiology: Find out the prevalence of Esophageal Cancer by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Esophageal Cancer products: Identify key products marketed and prescribed for Esophageal Cancer by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Esophageal Cancer market size: Find out the market size for Esophageal Cancer drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Esophageal Cancer drug sales: Find out the sales of Esophageal Cancer drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Esophageal Cancer drugs sales forecast: Sales forecast for Esophageal Cancer drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Esophageal Cancer market share analysis: Find out the market shares of Esophageal Cancer drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Esophageal Cancer drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Esophageal Cancer market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Esophageal Cancer market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Esophageal Cancer: Disease Overview
1.1. Esophageal Cancer Symptoms
1.2. Esophageal Cancer Etiology
1.3. Esophageal Cancer Diagnosis
1.4. Esophageal Cancer Treatment Options
2. Esophageal Cancer Pipeline Insights
2.1. Esophageal Cancer Phase 3 Clinical Trials
2.2. Esophageal Cancer Phase 2 Clinical Trials
2.3. Esophageal Cancer Phase 1 Clinical Trials
3. Esophageal Cancer Epidemiology Analysis
4. US Esophageal Cancer Market Insights
4.1. Marketed Products for Esophageal Cancer in US
4.2. US Esophageal Cancer Market Size & Forecast
4.3. US Esophageal Cancer Product Sales Forecast
4.4. US Esophageal Cancer Market Share Analysis
5. Germany Esophageal Cancer Market Insights
5.1. Marketed Products for Esophageal Cancer in Germany
5.2. Germany Esophageal Cancer Market Size & Forecast
5.3. Germany Esophageal Cancer Product Sales Forecast
5.4. Germany Esophageal Cancer Market Share Analysis
6. France Esophageal Cancer Market Insights
6.1. Marketed Products for Esophageal Cancer in France
6.2. France Esophageal Cancer Market Size & Forecast
6.3. France Esophageal Cancer Product Sales Forecast
6.4. France Esophageal Cancer Market Share Analysis
7. Italy Esophageal Cancer Market Insights
7.1. Marketed Products for Esophageal Cancer in Italy
7.2. Italy Esophageal Cancer Market Size & Forecast
7.3. Italy Esophageal Cancer Product Sales Forecast
7.4. Italy Esophageal Cancer Market Share Analysis
8. Spain Esophageal Cancer Market Insights
8.1. Marketed Products for Esophageal Cancer in Spain
8.2. Spain Esophageal Cancer Market Size & Forecast
8.3. Spain Esophageal Cancer Product Sales Forecast
8.4. Spain Esophageal Cancer Market Share Analysis
9. UK Esophageal Cancer Market Insights
9.1. Marketed Products for Esophageal Cancer in UK
9.2. UK Esophageal Cancer Market Size & Forecast
9.3. UK Esophageal Cancer Product Sales Forecast
9.4. UK Esophageal Cancer Market Share Analysis
10. Europe Esophageal Cancer Market Insights
10.1. Europe Esophageal Cancer Market Size & Forecast
10.2. Europe Esophageal Cancer Product Sales Forecast
10.3. Europe Esophageal Cancer Market Share Analysis
11. Japan Esophageal Cancer Market Insights
11.1. Marketed Products for Esophageal Cancer in Japan
11.2. Japan Esophageal Cancer Market Size & Forecast
11.3. Japan Esophageal Cancer Product Sales Forecast
11.4. Japan Esophageal Cancer Market Share Analysis
12. Global Esophageal Cancer Market Insights
12.1. Global Esophageal Cancer Market Size & Forecast
12.2. Global Esophageal Cancer Product Sales Forecast
12.3. Global Esophageal Cancer Market Share Analysis
13. Research Methodology
LIST OF TABLES
Table 1: Esophageal Cancer Phase 3 Clinical Trials, Global, 2017
Table 2: Esophageal Cancer Phase 2 Clinical Trials, Global, 2017
Table 3: Esophageal Cancer Phase 1 Clinical Trials, Global, 2017
Table 4: Esophageal Cancer Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Esophageal Cancer in US, 2017
Table 6: US Esophageal Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Esophageal Cancer Product Sales ($mn), 2012 - 2021
Table 8: US Esophageal Cancer Market Trends, 2012 - 2021
Table 9: Marketed Products for Esophageal Cancer in Germany, 2017
Table 10: Germany Esophageal Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Esophageal Cancer Product Sales ($mn), 2012 - 2021
Table 12: Germany Esophageal Cancer Market Trends, 2012 - 2021
Table 13: Marketed Products for Esophageal Cancer in France, 2017
Table 14: France Esophageal Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Esophageal Cancer Product Sales ($mn), 2012 - 2021
Table 16: France Esophageal Cancer Market Trends, 2012 - 2021
Table 17: Marketed Products for Esophageal Cancer in Italy, 2017
Table 18: Italy Esophageal Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Esophageal Cancer Product Sales ($mn), 2012 - 2021
Table 20: Italy Esophageal Cancer Market Trends, 2012 - 2021
Table 21: Marketed Products for Esophageal Cancer in Spain, 2017
Table 22: Spain Esophageal Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Esophageal Cancer Product Sales ($mn), 2012 - 2021
Table 24: Spain Esophageal Cancer Market Trends, 2012 - 2021
Table 25: Marketed Products for Esophageal Cancer in UK, 2017
Table 26: UK Esophageal Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Esophageal Cancer Product Sales ($mn), 2012 - 2021
Table 28: UK Esophageal Cancer Market Trends, 2012 - 2021
Table 29: Europe Esophageal Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Esophageal Cancer Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Esophageal Cancer in Japan, 2017
Table 32: Japan Esophageal Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Esophageal Cancer Product Sales ($mn), 2012 - 2021
Table 34: Japan Esophageal Cancer Market Trends, 2012 - 2021
Table 35: Global Esophageal Cancer Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Esophageal Cancer Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Esophageal Cancer Pipeline by Phase (%), Global, 2017
Figure 2: Esophageal Cancer Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Esophageal Cancer Market Size ($mn), 2012 - 2021
Figure 4: US Esophageal Cancer Product Sales ($mn), 2012 - 2021
Figure 5: US Esophageal Cancer Market Share by Products (%), 2016
Figure 6: US Esophageal Cancer Market - Future Market Share (%), 2021
Figure 7: Germany Esophageal Cancer Market Size ($mn), 2012 - 2021
Figure 8: Germany Esophageal Cancer Product Sales ($mn), 2012 - 2021
Figure 9: Germany Esophageal Cancer Market Share by Products (%), 2016
Figure 10: Germany Esophageal Cancer Market - Future Market Share (%), 2021
Figure 11: France Esophageal Cancer Market Size ($mn), 2012 - 2021
Figure 12: France Esophageal Cancer Product Sales ($mn), 2012 - 2021
Figure 13: France Esophageal Cancer Market Share by Products (%), 2016
Figure 14: France Esophageal Cancer Market - Future Market Share (%), 2021
Figure 15: Italy Esophageal Cancer Market Size ($mn), 2012 - 2021
Figure 16: Italy Esophageal Cancer Product Sales ($mn), 2012 - 2021
Figure 17: Italy Esophageal Cancer Market Share by Products (%), 2016
Figure 18: Italy Esophageal Cancer Market - Future Market Share (%), 2021
Figure 19: Spain Esophageal Cancer Market Size ($mn), 2012 - 2021
Figure 20: Spain Esophageal Cancer Product Sales ($mn), 2012 - 2021
Figure 21: Spain Esophageal Cancer Market Share by Products (%), 2016
Figure 22: Spain Esophageal Cancer Market - Future Market Share (%), 2021
Figure 23: UK Esophageal Cancer Market Size ($mn), 2012 - 2021
Figure 24: UK Esophageal Cancer Product Sales ($mn), 2012 - 2021
Figure 25: UK Esophageal Cancer Market Share by Products (%), 2016
Figure 26: UK Esophageal Cancer Market - Future Market Share (%), 2021
Figure 27: Europe Esophageal Cancer Market Size ($mn), 2012 - 2021
Figure 28: Europe Esophageal Cancer Product Sales ($mn), 2012 - 2021
Figure 29: Europe Esophageal Cancer Market Share by Products (%), 2016
Figure 30: Europe Esophageal Cancer Market - Future Market Share (%), 2021
Figure 31: Japan Esophageal Cancer Market Size ($mn), 2012 - 2021
Figure 32: Japan Esophageal Cancer Product Sales ($mn), 2012 - 2021
Figure 33: Japan Esophageal Cancer Market Share by Products (%), 2016
Figure 34: Japan Esophageal Cancer Market - Future Market Share (%), 2021
Figure 35: Global Esophageal Cancer Market Size ($mn), 2012 - 2021
Figure 36: Global Esophageal Cancer Product Sales ($mn), 2012 - 2021
Figure 37: Global Esophageal Cancer Market Share by Products (%), 2016
Figure 38: Global Esophageal Cancer Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report